Brief: Adagio Medical To List On Nasdaq Through Business Combination With ARYA Sciences Acquisition Corp IV

Adagio Medical Holdings

14/02/2024 11:20

Feb 14 (Reuters) - ARYA Sciences Acquisition Corp IV
 ARYD.O :
    * ADAGIO MEDICAL TO LIST ON NASDAQ THROUGH BUSINESS
COMBINATION
WITH ARYA SCIENCES ACQUISITION CORP IV, ENABLING FURTHER
COMMERCIAL AND CLINICAL DEVELOPMENT OF INNOVATIVE CARDIAC
ABLATION TECHNOLOGIES
    * ARYA SCIENCES ACQUISITION CORP IV - TRANSACTION IMPLIES A
POST-TRANSACTION FULLY DILUTED EQUITY VALUE OF COMBINED COMPANY
OF $128 MILLION
    * ARYA SCIENCES ACQUISITION CORP IV: COMBINED CO EXPECTS TO
RECEIVE ABOUT $42 MILLION FROM EQUITY AND CONVERTIBLE NOTE
INVESTORS AT CLOSING
    * ARYA SCIENCES ACQUISITION CORP IV -  TRANSACTION IMPLIES A
POST-TRANSACTION FULLY DILUTED ENTERPRISE VALUE OF $113 MILLION
OF COMBINED CO
    * ARYA SCIENCES ACQUISITION CORP IV: INC." COMBINED CO'S
COMMON
STOCK EXPECTED TO BE LISTED ON NASDAQ UNDER TICKER SYMBOL "ADGM"
    * ARYA SCIENCES ACQUISITION CORP IV -  CURRENT INVESTORS IN
ADAGIO
MEDICAL ARE EXPECTED TO OWN ABOUT 10.2% OF COMBINED CO
    * ARYA SCIENCES ACQUISITION CORP IV -  PERCEPTIVE AND ARYA
SCIENCES HOLDINGS IV COLLECTIVELY, ARE EXPECTED TO HOLD ABOUT
58.2% OF COMBINED CO

Source text for Eikon:  ID:nPnnrQVpa 
Further company coverage:  ARYD.O 

 ((Reuters.Briefs@thomsonreuters.com;))